NASDAQ:CHGA Avalon GloboCare Q1 2025 Earnings Results & Report $2.02 +0.01 (+0.50%) As of 10/9/2026 04:00 PM Eastern Avalon GloboCare reported Q1 2025 earnings on May 13, 2025. The company reported EPS of -$28.60. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ1 2025Report DateMay 13, 2025TimeAfter Market ClosesConference Call8:00 AM ET Avalon GloboCare EPS ResultsActual EPS-$28.60Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AAvalon GloboCare Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AConference Call ResourcesQuarterly Report (10-Q)Earnings HistoryCompany ProfilePowered by Earnings DocumentsQuarterly report(10-Q) Avalon GloboCare Q1 2025 Earnings FAQ Did Avalon GloboCare beat earnings estimates for Q1 2025? Avalon GloboCare (NASDAQ:CHGA) reported earnings of -$28.60 per share for Q1 2025. The report was announced on Tuesday, May 13, 2025. Avalon GloboCare Earnings HeadlinesChange Agents Joins Association of the United States Army, Expanding Engagement Across U.S. Defense EcosystemSeptember 24, 2026 | globenewswire.comChange Agents Regains Compliance with Nasdaq's Minimum Bid Price RequirementSeptember 17, 2026 | globenewswire.comDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in could be a costly mistake. He calls it among the most overhyped, overvalued large-cap offerings ever pushed onto everyday investors. Tilson believes a rare economic event is approaching - one with serious consequences for your portfolio this summer. He has prepared a free analysis outlining what he sees and the specific steps he recommends taking now.October 11 at 1:00 AM | Stansberry Research (Ad)Der aktuelle Kurs der Change Agents Corp Aktie beträgt 2,8900.September 1, 2026 | de.investing.comChange Agents Completes Phase 2 of its Catch-Up Agentic AI Video Studio Platform; Development led by Caylent with Funding from Amazon Web Services GrantAugust 31, 2026 | globenewswire.comChange Agents Accepted into Seagate Partner Program, Expanding Access to AI Infrastructure EcosystemAugust 28, 2026 | globenewswire.comSee More Avalon GloboCare Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Avalon GloboCare? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Avalon GloboCare and other key companies, straight to your email. Email Address About Avalon GloboCareAvalon GloboCare (NASDAQ:CHGA) is a biotechnology company focused on developing cell-based and regenerative medicine technologies. Its work has included cellular immunotherapies, exosome-based products and other platforms intended to support the treatment of cancer and other serious medical conditions. The company has also pursued activities involving cell and gene therapy development, biobanking and related laboratory services. Avalon GloboCare has described its business as spanning research, product development and potential commercialization through collaborations and strategic partnerships. Avalon GloboCare was founded in the United States and has historically been associated with operations in New Jersey. Publicly available company materials have identified David Jin as a senior executive, although the company’s operating status, leadership and securities information may have changed. Avalon GloboCare has historically traded under the symbol AVCO; the symbol provided, CHGA, could not be independently confirmed as its current listing.View Avalon GloboCare ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 10/05 - 10/09Q3 Earnings Could Blow Past Consensus—Be Ready for What Comes NextDelta Air Lines Faces a Fuel Crisis—But There's a Silver LiningPalantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November EarningsApplied Digital’s Hidden Moat Could Unlock Massive UpsideLevi's Stock Dip Reveals Value Opportunity Despite Q3 HeadwindsTilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform Upcoming Earnings Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026)BlackRock (10/14/2026)Morgan Stanley (10/14/2026)Progressive (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
